Associate Professor Puhong Zhang



view more

Dr. Puhong Zhang is a researcher in the field of epidemiological research, with a focus on chronic non-communicable diseases (NCDs) such as diabetes and hypertension. His expertise extends to primary health care, public nutrition and lifestyle, maternal and child health, and digital health interventions. He has secured 20 grants from notable institutions like the GACD and IDF, totaling approximately 170 million CNY. His academic contributions are extensive, with over 132 publications, including 2 books and 104 peer-reviewed articles.

My Grants


  • 2015-2017 Co-PI. Development of clinical pathway of diagnosis and treatment for hospitalized patients comorbid with T2DM and OSA (DOSA2 study). Beijing Science and Technology Bureau (D141107005314005): 600K.
  • 2015-2018. PI. China Center for mHealth Innovation (CCmHI), a collection of mHealth research program to support people to receive/provide better health services. Qualcomm Wireless Reach: US$1.8M.
  • 2016-2018. PI. mHealth platform for maternal and child health care (1000-day Project). CCTF (China Children and Teenagers’ Fund): US$575K.
  • 2015-2019. PI-China. Systematic Medical Assessment, Referral and Treatment for Diabetes care in China using Lay Family Health Promoters (SMART Diabetes study). Australia Government NHMRC- Global Alliance for Chronic Diseases (Application ID: APP1094712): AU$1,38M.
  • 2016-2021. PI. Project 5 (Smart Diet study) in Development and scale-up of key technologies on nutrition and behavior change for cardiovascular health --- National Key Basic Research Program on Major Chronic Non-communicable Disease in China. MOST (Ministry of Science and Technology of People’s Republic of China; application ID: 2016YFC1300200): 1M.
  • 2017-2020. Co-PI. Road to hierarchical diabetes management at primary care settings in China (ROADMAP Study). Bethune Charitable Foundation:10.1M.
  • 2017-2021 Co-PI. NIHR Unit Action on Salt China (ASC). National Institute for Health Research (NIHR) (Project number 16/136/77: NIHR Global Health Research Unit): £6.6M.


  • 2004-2006.           PI. Surveillance of chronic diseases and risk factors in Beijing adults (2005) (16861 randomized citizens were investigated). Beijing Health Bureau: 1,35M.
  • 2006-2008. PI. Establishment of Family Health Promotor program in urban area of Beijing. Beijing Health Bureau (118-package-project): 750k.
  • 2010-2013. PI. Establishment and assessment of a school-student-family interactive healthy diet promotion model. DANONE Foundation (DIC2010-09): 200K.
  • 2011-2012. Co-PI/PM. Type 1 Diabetes in China: building a comprehensive evidence base of its coverage, cost and care (3C study). International Diabetes Federation (IDF): 2.87M.
  • 2011-2013. Co-PI/PM. Diabetes and Obstructive Sleep Apnea in China (DOSA 1 study). ResMed Foundation: US$100K.
  • 2011-2016. Co-PI/PM. Observational Registry for Basal Insulin Treatment in China (ORBIT study). Sanofi-Aventis (China) Investment Co., Ltd.: 37.8M.
  • 2014-2015. PI. Efficacy of Telmisartan 40mg and Hydrochlorothiazide 25mg monotherapy in high sodium intake patients with mild to moderate hypertension: a multicenter randomized double-blinded parallel controlled trial (THAT study)        . Ministry of Science and Technology of P.R. China (2013 BAI05B02): 600K.

My Research Activities

Dr. Zhang is leading several research projects with the purpose of improving healthy lifestyles and control of body weight, diabetes and hypertension based on mHealth technologies. His research interests mainly focus on innovative mHealth and diabetes research.

View less


China office, The George Institute for Global Health